1. Home
  2. JAGX vs RAYA Comparison

JAGX vs RAYA Comparison

Compare JAGX & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • RAYA
  • Stock Information
  • Founded
  • JAGX 2013
  • RAYA 2019
  • Country
  • JAGX United States
  • RAYA China
  • Employees
  • JAGX N/A
  • RAYA N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • JAGX Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • JAGX Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • JAGX 3.9M
  • RAYA 4.3M
  • IPO Year
  • JAGX N/A
  • RAYA 2022
  • Fundamental
  • Price
  • JAGX $1.28
  • RAYA $3.61
  • Analyst Decision
  • JAGX Strong Buy
  • RAYA
  • Analyst Count
  • JAGX 1
  • RAYA 0
  • Target Price
  • JAGX $60.00
  • RAYA N/A
  • AVG Volume (30 Days)
  • JAGX 111.9K
  • RAYA 22.3K
  • Earning Date
  • JAGX 11-17-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • JAGX N/A
  • RAYA N/A
  • EPS Growth
  • JAGX N/A
  • RAYA N/A
  • EPS
  • JAGX N/A
  • RAYA N/A
  • Revenue
  • JAGX $11,785,000.00
  • RAYA $30,300,360.00
  • Revenue This Year
  • JAGX $22.41
  • RAYA $20.95
  • Revenue Next Year
  • JAGX $30.00
  • RAYA N/A
  • P/E Ratio
  • JAGX N/A
  • RAYA N/A
  • Revenue Growth
  • JAGX 12.45
  • RAYA 49.10
  • 52 Week Low
  • JAGX $1.10
  • RAYA $3.13
  • 52 Week High
  • JAGX $33.25
  • RAYA $736.99
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 32.53
  • RAYA 49.24
  • Support Level
  • JAGX $1.10
  • RAYA $3.13
  • Resistance Level
  • JAGX $1.98
  • RAYA $4.15
  • Average True Range (ATR)
  • JAGX 0.20
  • RAYA 0.37
  • MACD
  • JAGX -0.04
  • RAYA -0.03
  • Stochastic Oscillator
  • JAGX 19.00
  • RAYA 72.92

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: